Nitric Oxide, Inflammation, Lipid Profile, and Cortisol in Normal- and Overweight Women With Fibromyalgia

Biological Research for Nursing

Volumn 18, Issue 2, 2016, Pages 138-146

  Rus, Alma ^a   Molina, Francisco ^a   Gassó, Manuela ^b   Camacho, Maria Victoria ^b   Peinado, Maria Ángeles ^a   Moral, Maria Luisa del ^a  

^a UNIVERSITY OF JAÉN   (Spain)

^b Hosp Univ Ciudad de Jaén   (Spain)

Author keywords

apolipoprotein B; C reactive protein; fibromyalgia; overweight

Indexed keywords

APOLIPOPROTEIN B; BIOLOGICAL MARKER; C REACTIVE PROTEIN; HYDROCORTISONE; LIPID; NITRIC OXIDE;

ADULT; BLOOD; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; COMPARATIVE STUDY; COMPLICATION; CROSS-SECTIONAL STUDY; FEMALE; FIBROMYALGIA; HUMAN; INFLAMMATION; METABOLISM; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; QUESTIONNAIRE; SPAIN;

ADULT; APOLIPOPROTEINS B; BIOMARKERS; BODY MASS INDEX; BODY WEIGHT; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FIBROMYALGIA; HUMANS; HYDROCORTISONE; INFLAMMATION; LIPIDS; MIDDLE AGED; NITRIC OXIDE; OBESITY; SPAIN; SURVEYS AND QUESTIONNAIRES;

EID: 84959327086     PISSN: 10998004     EISSN: 15524175     Source Type: Journal    
DOI: 10.1177/1099800415591035     Document Type: Article

References (44)

1. S.AkkuşM.NaziroğluS.ErişK.YalmanN.YilmazM.Yener (2009). Levels of lipid peroxidation, nitric oxide, and antioxidant vitamins in plasma of patients with fibromyalgia. Cell Biochemistry and Function, 27, 181–185.
2. L.ArranzM.A.CanelaM.Rafecas (2012). Relationship between body mass index, fat mass and lean mass with SF-36 quality of life scores in a group of fibromyalgia patients. Rheumatology International, 32, 3605–3611. doi:10.1007/s00296-011-2250-y
3. L.BazzichiC.GiacomelliF.De FeoT.GiulianoA.RossiM.Doveri…S.Bombardieri (2007). Antipolymer antibody in Italian fibromyalgic patients. Arthritis Research & Therapy, 9, R86.
4. M.E.BoteJ.J.GarcíaM.D.HinchadoE.Ortega (2012). Inflammatory/stress feedback dysregulation in women with fibromyalgia. Neuroimmunomodulation, 19, 343–351.
5. L.A.BradleyD.A.WeigentA.SotolongoG.S.AlorconR.E.ArnoldL.R.Cianfrini (2000). Blood serum levels of nitric oxide are elevated in women with fibromyalgia: Possible contributions to central and peripheral sensitization. Arthritis & Rheumatology, 43, 173.
6. T.M.BrownS.GargA.B.ChandranM.McNettS.L.SilvermanN.Hadker (2012). The impact of “best-practice” patient care in fibromyalgia on practice economics. Journal of Evaluation in Clinical Practice, 18, 793–798. doi:10.1111/j.1365-2753.2011.01678.x
7. M.D.CorderoE.Alcocer-GómezF.J.Cano-GarcíaB.Sánchez-DomínguezP.Fernández-RiejoA.M.Moreno Fernández…M.De Miguel (2014). Clinical symptoms in fibromyalgia are associated to overweight and lipid profile. Rheumatology International, 34, 419–422.
8. L.J.CroffordE.A.YoungN.C.EnglebergA.KorszunC.B.BruckschL.A.McClure…M.A.Demitrack (2004). Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome. Brain, Behavior, and Immunity, 18, 314–325.
9. T.EschG.B.StefanoG.L.FricchioneH.Benson (2002). Stress-related diseases—a potential role for nitric oxide. Medical Science Monitor, 8, RA103–RA118.
10. G.FatimaS.K.DasA.A.MahdiN.S.VermaF.H.KhanA.M.Tiwari…B.Anjum (2013). Circadian rhythm of serum cortisol in female patients with fibromyalgia syndrome. Indian Journal of Clinical Biochemistry, 28, 181–184.
11. K.R.FeingoldC.Grunfeld (1992). Role of cytokines in inducing hyperlipidemia. Diabetes, 41, 97–101.
12. R.P.FreitasT.M.LemosM.H.SpyridesM.B.Sousa (2012). Influence of cortisol and DHEA-S on pain and other symptoms in post menopausal women with fibromyalgia. Journal of Back and Musculoskeletal Rehabilitation, 25, 245–252.
13. A.GeissN.RohlederF.Anton (2012). Evidence for an association between an enhanced reactivity of interleukin-6 levels and reduced glucocorticoid sensitivity in patients with fibromyalgia. Psychoneuroendocrinology, 37, 671–684.
14. A.GurR.CevikA.J.SaracL.ColpanS.Em (2004). Hypothalamic-pituitary-gonadal axis and cortisol in young women with primary fibromyalgia: The potential roles of depression, fatigue, and sleep disturbance in the occurrence of hypocortisolism. Annals of the Rheumatic Diseases, 63, 1504–1506.
15. A.GurP.Oktayoglu (2008). Status of immune mediators in fibromyalgia. Current Pain and Headache Reports, 12, 175–181.
16. G.GurerO.F.SendurC.Ay (2006). Serum lipid profile in fibromyalgia women. Clinical Rheumatology, 25, 300–303.
17. S.HaliloğluA.CarliogluE.SahinerY.KaraaslanA.Kosar (2014). Mean platelet volume in patients with fibromyalgia. Zeitschrift für Rheumatologie, 73, 742–745.
18. M.E.HernandezE.BecerrilM.PerezP.LeffB.AntonS.Estrada…L.Pavon (2010). Proinflammatory cytokine levels in fibromyalgia patients are independent of body mass index. BMC Research Notes, 3, 156.
19. E.L.KanabrockiM.GeorgeR.C.HermidaH.L.MessmoreM.D.RyanD.E.Ayala…B.A.Nemchausky (2001). Day-night variations in blood levels of nitric oxide, T-TFPI, and E-selectin. Clinical and Applied Thrombosis/Hemostasis, 7, 339–345.
20. E.KasikciogluM.DinlerE.Berker (2006). Reduced tolerance of exercise in fibromyalgia may be a consequence of impaired microcirculation initiated by deficient action of nitric oxide. Medical Hypotheses, 66, 950–952.
21. D.L.KatzL.GreeneA.AliZ.Faridi (2007). The pain of fibromyalgia syndrome is due to muscle hypoperfusion induced by regional vasomotor dysregulation. Medical Hypotheses, 69, 517–525.
22. S.K.KimK.S.KimY.S.LeeS.H.ParkJ.Y.Choe (2010). Arterial stiffness and proinflammatory cytokines in fibromyalgia syndrome. Clinical and Experimental Rheumatology, 28, S71–S77.
23. M.La RubiaA.RusF.MolinaM.L.Del Moral (2013). Is fibromyalgia-related oxidative stress implicated in the decline of physical and mental health status?Clinical and Experimental Rheumatology, 31, S121–S127.
24. A.A.LarsonS.L.GiovengoI.J.RussellJ.E.Michalek (2000). Changes in the concentrations of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia: Implications for nitric oxide pathways. Pain, 87, 201–211.
25. E.G.LentjesE.N.GriepJ.W.BoersmaF.P.RomijnE.R.de Kloet (1997). Glucocorticoid receptors, fibromyalgia and low back pain. Psychoneuroendocrinology, 22, 603–614.
26. A.J.MasL.CarmonaM.ValverdeB.Ribas, & EPISER Study Group. (2008). Prevalence and impact of fibromyalgia on function and quality of life in individuals from the general population: Results from a nationwide study in Spain. Clinical and Experimental Rheumatology, 26, 519–526.
27. V.MenziesD.E.Lyon (2010). Integrated review of the association of cytokines with fibromyalgia and fibromyalgia core symptoms. Biological Research for Nursing, 11, 387–394. doi:10.1177/1099800409348328
28. L.NeumannE.LernerY.GlazerA.BolotinA.SheferD.Buskila (2008). A cross-sectional study of the relationship between body mass index and clinical characteristics, tenderness measures, quality of life, and physical functioning in fibromyalgia patients. Clinical Rheumatology, 27, 1543–1547.
29. A.OkifujiD.H.BradshawC.Olson (2009). Evaluating obesity in fibromyalgia: Neuroendocrine biomarkers, symptoms, and functions. Clinical Rheumatology, 28, 475–478.
30. A.OnatH.OzhanG.CanG.HergençA.KarabulutS.Albayrak (2007). Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks. Anatolian Journal of Cardiology, 7, 128–133.
31. S.OzgocmenO.Ardicoglu (2000). Lipid profile in patients with fibromyalgia and myofascial pain syndromes. Yonsei Medical Journal, 41, 541–545.
32. S.OzgocmenH.OzyurtS.SogutO.AkyolO.ArdicogluH.Yildizhan (2006). Antioxidant status, lipid peroxidation and nitric oxide in fibromyalgia: Etiologic and therapeutic concerns. Rheumatology International, 26, 598–603.
33. M.L.Pall (2007). Nitric oxide synthase partial uncoupling as a key switching mechanism for the NO/ONOO- cycle. Medical Hypotheses, 69, 821–825.
34. J.C.ReeserE.PayneT.KitchnerC.A.McCarty (2011). Apolipoprotein e4 genotype increases the risk of being diagnosed with posttraumatic fibromyalgia. Physical Medicine and Rehabilitation, 3, 193–197. doi:10.1016/j.pmrj.2010.12.009
35. P.M.RidkerC.H.HennekensJ.E.BuringN.Rifai (2000). C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. New England Journal of Medicine, 342, 836–843.
36. A.RusM.L.del MoralF.MolinaM.A.Peinado (2011). Upregulation of cardiac NO/NOS system during short-term hypoxia and the subsequent reoxygenation period. European Journal of Histochemistry, 55, 90–96.
37. A.A.SaberM.J.BorosT.ManclM.H.ElgamalS.SongT.Wisadrattanapong (2008). The effect of laparoscopic Roux-en-Y gastric bypass on fibromyalgia. Obesity Surgery, 18, 652–655.
38. G.Sadeghi-HashjinM.AbuhosseiniS.Asri-Rezaei (2009). Role of nitric oxide in the plasma lipid profile in the rabbits. Archives of Medical Science, 5(3): 308–312.
39. O.F.SendurY.TuranE.TastabanC.YeniseyM.Serter (2009). Serum antioxidants and nitric oxide levels in fibromyalgia: A controlled study. Rheumatology International, 29, 629–633.
40. M.E.ThompsonA.Barkhuizen (2003). Fibromyalgia, hepatitis C infection, and the cytokine connection. Current Pain and Headache Reports, 7, 342–347.
41. M.VisserL.M.BouterG.M.McQuillanM.H.WenerT.B.Harris (1999). Elevated C-reactive protein levels in overweight and obese adults. Journal of the American Medical Association, 282, 2131–3135.
42. D.J.WallaceM.Linker-IsraeliD.HalleguaS.SilvermanD.SilverM.H.Weisman (2001). Cytokines play an aetiopathogenetic role in fibromyalgia: A hypothesis and pilot study. Rheumatology, 40, 743–749.
43. H.WangM.MoserM.SchiltenwolfM.Buchner (2008). Circulating cytokine levels compared to pain in patients with fibromyalgia—a prospective longitudinal study over 6 months. Journal of Rheumatology, 35, 1366–1370.
44. Y.XiaoW.L.HaynesJ.E.MichalekI.J.Russell (2013). Elevated serum high-sensitivity C-reactive protein levels in fibromyalgia syndrome patients correlate with body mass index, interleukin-6, interleukin-8, erythrocyte sedimentation rate. Rheumatology International, 33, 1259–1264.